Clinical Trials | December 20, 2022
Company to open new headquarters in 2024
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
